title: [Current advances and present-day issues in mucoviscidosis].
authors.forename: N I
authors.initials: NI
authors.lastname: Kapranov
authors.forename: N Iu
authors.initials: NIu
authors.lastname: Kashirskaia
authors.forename: D M
authors.initials: DM
authors.lastname: Moin
authors.forename: N V
authors.initials: NV
authors.lastname: Petrova
authors.forename: O I
authors.initials: OI
authors.lastname: Simonova
authors.forename: Z A
authors.initials: ZA
authors.lastname: Khafizova
authors.forename: L A
authors.initials: LA
authors.lastname: Shabalova
mesh_terms: D000293:Adolescent; D000584:Amiloride / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000235:genetics / Q000628:therapy; D005260:Female; D016041:Heart-Lung Transplantation; D006801:Humans; D007223:Infant; D016040:Lung Transplantation; D008297:Male; D011247:Pregnancy; D011296:Prenatal Diagnosis; D011379:Prognosis; D011480:Protease Inhibitors / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D011480:Protease Inhibitors; D000584:Amiloride